These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 28189004

  • 1. miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene Therapy.
    Suzuki T, Sakurai F, Nakamura SI, Kouyama E, Kawabata K, Kondoh M, Yagi K, Mizuguchi H.
    Mol Ther; 2008 Oct; 16(10):1719-1726. PubMed ID: 28189004
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of miR-122-regulated suicide gene therapy for hepatocellular carcinoma in an orthotopic mouse model.
    Wang G, Dong X, Tian W, Lu Y, Hu J, Liu Y, Yuchi J, Wu X.
    Chin J Cancer Res; 2013 Dec; 25(6):646-55. PubMed ID: 24385691
    [Abstract] [Full Text] [Related]

  • 5. Transduction Properties of an Adenovirus Vector Containing Sequences Complementary to a Liver-Specific microRNA, miR-122a, in the 3'-Untranslated Region of the E4 Gene in Human Hepatocytes from Chimeric Mice with Humanized Liver.
    Sakurai F, Tsukamoto T, Ono R, Nishimae F, Shiota A, Iizuka S, Shimizu K, Sakai E, Ishida Y, Tateno C, Chayama K, Mizuguchi H.
    Biol Pharm Bull; 2021 Dec; 44(10):1506-1513. PubMed ID: 34602559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.
    Shimizu K, Sakurai F, Tomita K, Nagamoto Y, Nakamura S, Katayama K, Tachibana M, Kawabata K, Mizuguchi H.
    Mol Ther Methods Clin Dev; 2014 Dec; 1():14035. PubMed ID: 26015975
    [Abstract] [Full Text] [Related]

  • 9. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
    Mizuguchi H, Hayakawa T.
    Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a.
    Sakurai F, Furukawa N, Higuchi M, Okamoto S, Ono K, Yoshida T, Kondoh M, Yagi K, Sakamoto N, Katayama K, Mizuguchi H.
    Virus Res; 2012 May; 165(2):214-8. PubMed ID: 22342424
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M, Gao GP, Force SD, Chang MY, El Kouri C, Amin KM, Hughes JV, Wilson JM, Kaiser LR, Albelda SM.
    Hum Gene Ther; 1999 Feb 10; 10(3):463-75. PubMed ID: 10048398
    [Abstract] [Full Text] [Related]

  • 15. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
    Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, Litzky L, Kaiser LR, Albelda SM.
    Gene Ther; 2001 Jun 10; 8(12):946-53. PubMed ID: 11426335
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
    Sterman DH, Recio A, Vachani A, Sun J, Cheung L, DeLong P, Amin KM, Litzky LA, Wilson JM, Kaiser LR, Albelda SM.
    Clin Cancer Res; 2005 Oct 15; 11(20):7444-53. PubMed ID: 16243818
    [Abstract] [Full Text] [Related]

  • 19. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
    Brand K, Löser P, Arnold W, Bartels T, Strauss M.
    Gene Ther; 1998 Oct 15; 5(10):1363-71. PubMed ID: 9930342
    [Abstract] [Full Text] [Related]

  • 20. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP.
    Gene Ther; 2001 Apr 15; 8(7):568-78. PubMed ID: 11319624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.